文献速递免疫规划

撤稿:PIRES2-EGFP/CTB-UreI 疫苗在 BALB/c 小鼠模型中激活混合 Th1/Th2/Th17 免疫系统防御以对抗幽门螺杆菌感染

WITHDRAWN: PIRES2-EGFP/CTB-UreI vaccination activated a mixed Th1/Th2/Th17 immune system defense towards Helicobacter pylori infection in the BALB/c mice model.
PubMed 文献 · Vaccine · 2024-03-07

本文应编辑要求撤稿。文章在线发表后,科学界对其方法学(包括但不限于重大技术问题)及由此得出的结论提出关切。经 Vaccine 编辑部调查,确认数据存在严重缺陷,科学界的关切有效,故决定撤稿并致歉。

要点

  • 本文已被期刊撤稿。
  • 撤稿原因为数据存在严重缺陷。
  • 科学界对方法学及结论提出有效关切。

核心结论

  • 期刊编辑部认定该文数据存在严重缺陷,科学界提出的关切有效,决定撤稿。

研究设计与样本

  • 原文为在 BALB/c 小鼠模型中评估 PIRES2-EGFP/CTB-UreI 疫苗对抗幽门螺杆菌感染的实验研究,但已撤稿。

局限性

  • 原文自述数据在作为 Article in Press 在线发表后被认定存在严重缺陷。
  • 科学界对研究中使用的方法学(包括但不限于重大技术问题)及由此得出的结论提出关切。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This article has been withdrawn at the request of the Editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal. The data presented in the manuscript was deemed severely flawed after appearing online as an Article in Press. The scientific community raised concerns about the methodology (including but not limited to major technical issues) used in the study and the subsequent conclusions drawn from the presented experiments. After careful investigation, the Vaccine editorial office concluded that the data in the publication was indeed severely flawed and that the concerns raised by the scientific community were valid. Therefore, the journal editors decided to withdraw the article and sincerely apologize for any inconvenience caused.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ghasemifar S, Chabak O, Piri-Gharaghie T, et al. WITHDRAWN: PIRES2-EGFP/CTB-UreI vaccination activated a mixed Th1/Th2/Th17 immune system defense towards Helicobacter pylori infection in the BALB/c mice model. Vaccine. 2024. PMID: 38453620. doi:10.1016/j.vaccine.2024.02.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。